Not yet recruitingPhase 3NCT06452498
Preeclampsia Intervention Netherlands
Studying HELLP syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amsterdam UMC
- Principal Investigator
- R.C. Painter, Prof, MD, PhDAmsterdam UMC
- Intervention
- Metformin Hydrochloride(drug)
- Enrollment
- 180 enrolled
- Eligibility
- 18-50 years · FEMALE
- Timeline
- 2024 – 2028
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06452498 on ClinicalTrials.govOther trials for HELLP syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07151339Pilot Project Renal and Cardiovascular Tertiary Prevention in PreeclampsiaUniversity Hospital Schleswig-Holstein
- RECRUITINGNCT05500989PlacEntal Acute Atherosis RefLecting Subclinical AtherosclerosisMaastricht University Medical Center
- RECRUITINGNCT06377878The Preeclampsia RegistryPreeclampsia Foundation